» Articles » PMID: 38935224

Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2024 Jun 27
PMID 38935224
Authors
Affiliations
Soon will be listed here.
Abstract

A ketogenic diet (KD) is a high-fat, low-carbohydrate, and low-protein diet that exerts antiepileptic effects by attenuating spontaneous recurrent seizures, ameliorating learning and memory impairments, and modulating the gut microbiota composition. However, the role of the gut microbiome in the antiepileptic effects of a KD on temporal lobe epilepsy (TLE) induced by lithium-pilocarpine in adult rats is still unknown. Our study provides evidence demonstrating that a KD effectively mitigates seizure behavior and reduces acute-phase epileptic brain activity and that KD treatment alleviates hippocampal neuronal damage and improves cognitive impairment induced by TLE. We also observed that the beneficial effects of a KD are compromised when the gut microbiota is disrupted through antibiotic administration. Analysis of gut microbiota components via 16S rRNA gene sequencing in fecal samples collected from TLE rats fed either a KD or a normal diet. The Chao1 and ACE indices showed decreased species variety in KD-fed rats compared to TLE rats fed a normal diet. A KD increased the levels of Actinobacteriota, Verrucomicrobiota and Proteobacteria and decreased the level of Bacteroidetes. Interestingly, the abundances of Actinobacteriota and Verrucomicrobiota were positively correlated with learning and memory ability, and the abundance of Proteobacteria was positively correlated with seizure susceptibility. In conclusion, our study revealed the significant antiepileptic and neuroprotective effects of a KD on pilocarpine-induced epilepsy in rats, primarily mediated through the modulation of the gut microbiota. However, whether the gut microbiota mediates the antiseizure effects of a KD still needs to be better elucidated.

Citing Articles

Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice.

Ozcan E, Yu K, Dinh L, Lum G, Lau K, Hsu J Nat Commun. 2025; 16(1):987.

PMID: 39856104 PMC: 11759687. DOI: 10.1038/s41467-025-56091-7.


Maternal Gut Microbiome-Mediated Epigenetic Modifications in Cognitive Development and Impairments: A New Frontier for Therapeutic Innovation.

Nohesara S, Mostafavi Abdolmaleky H, Dickerson F, Pinto-Tomas A, Jeste D, Thiagalingam S Nutrients. 2025; 16(24.

PMID: 39770976 PMC: 11676351. DOI: 10.3390/nu16244355.


Necrotizing Enterocolitis and Neurodevelopmental Impairments: Microbiome, Gut, and Brain Entanglements.

Sha C, Jin Z, Ku S, Kogosov A, Yu S, Bergese S Biomolecules. 2024; 14(10).

PMID: 39456187 PMC: 11505939. DOI: 10.3390/biom14101254.


Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice.

Ozcan E, Yu K, Dinh L, Lum G, Lau K, Hsu J bioRxiv. 2024; .

PMID: 39131354 PMC: 11312565. DOI: 10.1101/2024.07.31.606041.

References
1.
Zuo D, Wang F, Rong W, Wen Y, Sun K, Zhao X . The novel estrogen receptor GPER1 decreases epilepsy severity and susceptivity in the hippocampus after status epilepticus. Neurosci Lett. 2020; 728:134978. DOI: 10.1016/j.neulet.2020.134978. View

2.
Thijs R, Surges R, OBrien T, Sander J . Epilepsy in adults. Lancet. 2019; 393(10172):689-701. DOI: 10.1016/S0140-6736(18)32596-0. View

3.
Ahola-Erkkila S, Carroll C, Peltola-Mjosund K, Tulkki V, Mattila I, Seppanen-Laakso T . Ketogenic diet slows down mitochondrial myopathy progression in mice. Hum Mol Genet. 2010; 19(10):1974-84. DOI: 10.1093/hmg/ddq076. View

4.
Halasz P, Ujma P, Fabo D, Bodizs R, Szucs A . Epilepsy as a derailment of sleep plastic functions may cause chronic cognitive impairment - A theoretical review. Sleep Med Rev. 2019; 45:31-41. DOI: 10.1016/j.smrv.2019.01.003. View

5.
McDonald T, Cervenka M . Ketogenic Diet Therapies for Seizures and Status Epilepticus. Semin Neurol. 2020; 40(6):719-729. PMC: 7883219. DOI: 10.1055/s-0040-1719077. View